Background
==========

Ultrasmall superparamagnetic particles of iron-oxide (SUPIO) particles can be used as a magnetic resonance imaging contrast (MRI) agent. Due to their dextran coating and small diameter (\<30 nm), they are phagocytised by inflammatory cells \[1\].

The aim of this study was to assess whether a novel acquisition/registration USPIO-MRI protocol could be used to assess myocardial cellular inflammation. Myocardial infarction and cardiac surgery was used to model myocardial inflammation \[2\]. An influx of macrophages can be seen in post-mortem histology, however the dynamics of in vivo patho-physiology is uncertain \[3\].

Methods
=======

16 patients underwent MRI 2-4 days after ST-elevation myocardial infarction (STEMI) at baseline and 24-hours after intravenous USPIO infusion (4 mg/kg; Ferumoxytol, AMAG; n=10) or no infusion (n=6). Between 5 and 28-days following on-pump coronary artery bypass graft (CABG) surgery, 32 patients underwent the same protocol with all patients receiving USPIO.

3T-MRI (Siemens Medical) was performed to optimise USPIO sensitivity. Baseline and 24-hour multi-echo T2\*-weighted sequences were spatially registered to generate an R2\* (1/T2\*) map to assess USPIO uptake. R2\* maps were spatially registered using custom software (Matlab/Analyze) to late gadolinium enhancement (LGE) images to confirm USPIO localisation in the infarct zone. CABG R2\* maps were analysed using a standard 17-segment model

Data comparing CABG to MI cohorts was analysed by one-way and repeated measures ANOVA with Dunn\'s post-test. Data comparing change in R2\* values within cohorts was analysed by Wilcoxon matched pairs test.

Results
=======

Consistent with reticuloendothelial uptake, R2\* values increased in the liver & spleen following USPIO administration. In the myocardial infarct, there was a large R2\* increase from 41.0±12.0 (baseline) to 155±45.0 s-1 (p\<0.001) at 24h. A lower magnitude response was seen in the remote myocardium from 39±3.2 to 80±14.9 s-1 (p\<0.002), consistent with myocardial inflammation that occurs post infarction \[4\[.

In CABG patients the R2\* signal increased: 45±7s-1 to 118± 22 s-1 at 24h (p\<0001). The increase in myocardial R2\* values was greater than in the remote myocardium of patients with STEMI, but lower than the infarct zone itself (p\<0.001 and p\<0.05 respectively).

Conclusions
===========

USPIO are taken up into inflamed myocardial tissue and can be quantitatively assessed using a multi-parameter MRI acquisition protocol with optimised spatial registration analysis based on a custom mutual information algorithm.

This represents a novel imaging technique of assessing myocardial inflammation, as well as providing a useful research tool in investigating tissue inflammation.
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